We think you have liked this presentation. If you wish to download it, please recommend it to your friends in any social system. Share buttons are a little bit lower. Thank you!
Presentation is loading. Please wait.
Published byHubert Wiggins
Modified over 5 years ago
Split-Course Palliative Radiotherapy for Advanced Non-small Cell Lung Cancer Su K. Metcalfe, MD, MPH, Michael T. Milano, MD, PhD, Kevin Bylund, MD, Therese Smudzin, BS, Philip Rubin, MD, Yuhchyau Chen, MD, PhD Journal of Thoracic Oncology Volume 5, Issue 2, Pages (February 2010) DOI: /JTO.0b013e3181c6eb20 Copyright © 2010 International Association for the Study of Lung Cancer Terms and Conditions
FIGURE 1 Kaplan-Meier estimates of overall survival for all patients.Journal of Thoracic Oncology 2010 5, DOI: ( /JTO.0b013e3181c6eb20) Copyright © 2010 International Association for the Study of Lung Cancer Terms and Conditions
FIGURE 2 Kaplan-Meier estimates of overall survival for patients with “wet” stage IIIB and IV disease versus other stages of non-small cell lung cancer (NSCLC). Journal of Thoracic Oncology 2010 5, DOI: ( /JTO.0b013e3181c6eb20) Copyright © 2010 International Association for the Study of Lung Cancer Terms and Conditions
FIGURE 3 Kaplan-Meier estimates of overall survival for patients who completed treatment versus those who did not complete entire treatment. Journal of Thoracic Oncology 2010 5, DOI: ( /JTO.0b013e3181c6eb20) Copyright © 2010 International Association for the Study of Lung Cancer Terms and Conditions
A2-06: Survival differences for non-Bronchioloalveolar Carcinoma (BAC) non-small-cell lung cancer (NSCLC) cases with ipsilateral intrapulmonary metastasis.
Split-Course Chemoradiotherapy for Locally Advanced Non-small Cell Lung Cancer: A Single-Institution Experience of 144 Patients Benjamin T. Gielda, MD,
Jarrod D. Predina, BA, Matthew M. Puc, MD, Meredith R
Primary Signet-Ring Carcinoma (SRC) of the Lung: A Population-Based Epidemiologic Study of 262 Cases with Comparison to Adenocarcinoma of the Lung Sai-Hong.
Erlotinib or Docetaxel for Second-Line Treatment of Non-small Cell Lung Cancer: A Real-World Cost-Effectiveness Analysis Ian Cromwell, MSc, Kimberly.
Carcinoma NOS is a Common Histologic Diagnosis and is Increasing in Proportion Among Non-small Cell Lung Cancer Histologies Sai-Hong Ignatius Ou, MD,
Phase II Study of Gefitinib, an Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor (EGFR-TKI), and Celecoxib, a Cyclooxygenase-2 (COX-2) Inhibitor,
Volume 13, Issue 12, Pages (December 2012)
Prognostic Significance of the Number of Lymph Nodes Removed at Lobectomy in Stage IA Non-small Cell Lung Cancer Sai-Hong Ignatius Ou, MD, PhD, Jason.
Disparities in Treatment of Patients with Inoperable Stage I Non–Small Cell Lung Cancer: A Population-Based Analysis Matthew Koshy, MD, Renuka Malik,
SC17.02 Lung Cancer in China: Challenges and Perspectives
Role of Postoperative Radiotherapy in Pathologic Stage IIIA (N2) Non–Small Cell Lung Cancer in a Prospective Nationwide Oncology Outcomes Database Alex.
Phase II Trial with Carboplatin and Bendamustine in Patients with Extensive Stage Small-Cell Lung Cancer Wolf Köster, MD, Andrea Heider, MD, Norbert.
Prognostic Significance of TAZ Expression in Resected Non-Small Cell Lung Cancer Mian Xie, MD, PhD, Li Zhang, MD, Chao-Sheng He, MD, Jin-Hui Hou, MD,
Prognostic Significance of C-Reactive Protein and Smoking in Patients with Advanced Non-small Cell Lung Cancer Treated with First-Line Palliative Chemotherapy
Susan C. Scott, MD, Nathan A. Pennell, MD, PhD
Ellen M. Schultz, MS, Gerard A. Silvestri, MD, MS, Michael K
Treatment and Prognosis of Isolated Local Relapse after Stereotactic Body Radiotherapy for Clinical Stage I Non-Small-Cell Lung Cancer Masatsugu Hamaji,
© 2023 SlidePlayer.com Inc. All rights reserved.